retatrutide mechanism of action triple agonist glp-1 gip glucagon Retatrutide, a agonist, delivered 30.3% weight loss at two years in Phase 3. The headlines state: → 70 lbs average loss on 12mg at 80 weeks (28.3% body weight) → Conceivable actions of retatrutide in
Description
The half-life of GIP and bioactive GLP-1 is only a few minutes [45,46] since they are inactivated by DPP-4 [47]
A pharmaceutical breakthrough GLP-1 receptor agonists work by mimicking hormones that regulate hunger and satiety, effectively helping people feel full sooner and eat less
doi:10.1042/bsr20241510 Li Z, Wu J, Song J, Wen Y
doi: 10.1016/j.japh.2023.10.002
Hsu CY, McCulloch CE, Iribarren C et al
